BMJ Best Practice – Comorbidities is the only point of care tool that supports the management of the whole patient by including guidance on the treatment of a patient’s acute condition alongside their pre-existing comorbidities. Healthcare professionals are prompted to consider the patient’s comorbidities when accessing treatment information. The tool then produces an initial management plan that is tailored to the unique needs of the patient.

Written by leading specialists, the tool provides tailored treatment advice based on the latest evidence and presented in a way that’s realistic for daily practice. It emphasises the most important take-home points and, where evidence is scarce or equivocal, expert opinion is provided.

Expert panel for BMJ Best Practice – Comorbidities

Dr Andrew Lewington, BSc MBBS MA (Ed) MD FRCP
Consultant Renal Physician
Honorary Associate Professor
Nephrology Department
Leeds Teaching Hospitals NHS Trust
Leeds
UK

Disclosures: AL is Associate Clinical Director of NIHR Leeds In-Vitro Diagnostics Co-operative,
Co-Chair of UK Kidney Research Consortium Renal Clinical Study Group, Member of Kidney Research UK Research Grant Committee, Committee Member of NICE Kidney Injury Clinical Guideline Update 2018-20, Committee Member of NICE Diagnostic Assessment for Point of Care Creatinine Testing 2018-19. AL attended the Acute Dialysis Quality Initiative Meeting in San Diego 2018 (accommodation expenses); AL was a speaker at the AKI & CRRT Conference in San Diego 2019 (travel and accommodation expenses), the AKI Conference in Coventry 2019 (travel expenses), and the NIHR AKI and Sepsis Meeting in Leeds 2019 (no expenses).

__________________________________________________________________________________________

Professor Martin Cowie, MD MSc FRCP FRCP (Ed) FESC FHFA FACC
Professor of Cardiology
Imperial College London (Royal Brompton Hospital)
London
UK

Disclosures: MC is a Non-Executive Director of NICE and Chair the Digital Health Committee of the European Society of Cardiology. MC’s university receives support for his research from Abbott, ResMed, Boston Scientific, and Medtronic. MC speaks at educational events and provides consultancy advice to a number of device, diagnostic, and pharmaceutical companies including Novartis, Servier, Bayer, Pfizer, AstraZeneca, Boehringer Ingelheim, Roche Diagnostics, Medtronic, Abbott, ResMed, and Boston Scientific. MC declares that none of these interests is directly related to topics advised on for this project.

__________________________________________________________________________________________

Dr Rachael Evans, MBChB, FRCP (UK), PhD
Associate Professor (Clinical)
University of Leicester
Honorary Consultant Respiratory Physician
Glenfield Hospital
Leicester
UK

Disclosures: RAE has been reimbursed for a GSK Advisory Board meeting on Physical Activity and Asthma in November 2016, and three Chiesi Education meetings for GPs on COPD care in 2019. RAE received a travel award for ERS 2017 from Chiesi and participated in the GSK clinical experience programme – respiratory in August 2018. RAE participated in the BTS/SIGN guidelines for asthma update 2016 (no fee).

__________________________________________________________________________________________

Professor Gerry Rayman, MD, FRCP
Consultant Physician and Head of Service
Diabetes and Endocrine Centre and the Diabetes Research Unit
Ipswich Hospitals NHS Trust
Ipswich
UK

Disclosures: GR has been paid for advisory board meetings with the following companies: Safoni Aventis, Abbott Diabetes UK, Lilly Diabetes, Bayer. GR has received lecture fees from Safoni Aventis, Abbott Diabetes UK, Lilly Diabetes, Novonordisk, Napp Pharmaceuticals Ltd.

________________________________________________________________________________________

Dr Martyn Patel, BMBcH, FRCP, MA
Consultant, Older People’s Medicine
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich
UK

Disclosures: MP has accepted speaker fees and/or travel expenses to deliver lectures from: University of East Anglia, Leicester University (speaker fees only); Astellas Pharma Ltd (speaker fees and travel expenses). MP has accepted travel expenses from Newton Europe to present a joint project conducted by his main employer (Norfolk and Norwich University Hospitals NHS Trust) and Newton Europe at the NHS Confederation conference (Manchester 2018). MP has accepted sponsorship for travel expenses and accommodation costs from Astellas Pharma Ltd to attend the European Geriatric Society Meeting (Lisbon 2016).

________________________________________________________________________________________

Dr Sotiris Posporelis,  MD, MRCPsych
Consultant Liaison Neuropsychiatrist
King’s College Hospital
South London and Maudsley NHS Foundation Trust
Honorary Senior Clinical Lecturer
Institute of Psychiatry, Psychology & Neuroscience
King’s College London
London
UK

Disclosures: SP declares that he has no competing interests.

__________________________________________________________________________________________

Caroline Ashley, MSc. FFRPS, FRPharmS
Lead Pharmacist Renal Services
Royal Free London NHS Foundation Trust
London
UK

Disclosure:

CA has attended advisory boards for Vifor Pharmaceuticals (IV iron) and Bayer (rivaroxaban) in the last 36 months for which she has received an honorarium.

__________________________________________________________________________________________

Registrar Contributors for BMJ Best Practice – Comorbidities

 

Dr Hamish McAuley,  MBBS BSc MRCP
Clinical Research Fellow
Specialist Registrar (ST5)
Department of Respiratory Sciences
University of Leicester
Respiratory Biomedic​al Research Unit
Glenfield Hospital
Leicester
UK

Disclosure: HM declares that he has no competing interests.